Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation
Status: Recruiting
Location: See all (13) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
⁃ Patients who meet all of the following conditions will be included:
• Patients ≥ 18 years undergoing transfemoral TAVI implantation scheduled, performed on an outpatient basis.
• Patients with percutaneous implant.
• Patients undergoing the procedure under superficial sedation or Local anesthesia.
• Patients with baseline narrow QRS that does not change after implantation, or definitive pacemaker carrier.
• Patients who have signed the informed consent.
Locations
Other Locations
Spain
Hospital Universitario A Coruña
RECRUITING
A Coruña
Hospital General Universitario Dr. Balmis
RECRUITING
Alicante
Hospital Clinico San Carlos
RECRUITING
Aravaca
Hospital Universitari Germans Trias I Pujol
RECRUITING
Badalona
Hospital de Santa Creu I Sant Pau
RECRUITING
Barcelona
Hospital Universitari Vall Hebron
RECRUITING
Barcelona
Hospital Universitario de Bellvitge
RECRUITING
L'hospitalet De Llobregat
Hospital Regional Universitario de Malaga
RECRUITING
Málaga
Hospital Universitario Central de Asturias
RECRUITING
Oviedo
Hospital Universitario de Navarra
RECRUITING
Pamplona
Hospital Clinico Universitario de Santiago
RECRUITING
Santiago De Compostela
Hospital Universitario Virgen Del Rocio
RECRUITING
Seville
Hospital Universitari i Politècnic la Fe
RECRUITING
Valencia
Contact Information
Primary
VICENTE SERRA GARCIA, MD
vctsrr@hotmail.com
0034932746155
Backup
FUNDACION EPIC
iepic@fundacionepic.org
0034987225638
Time Frame
Start Date: 2023-04-04
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 585
Treatments
Patients receiving transfemoral (TF) TAVI
TF TAVI
Related Therapeutic Areas
Sponsors
Leads: Fundación EPIC